Relationship between Renalase Expression and Kidney Disease: an Observational Study in 72 Patients Undergoing Renal Biopsy

Abstract

The relationship between the levels of renalase and changes in proteinuria, hypertension, renal function, renal tubular epithelial cell apoptosis and B-cell lymphoma-2 (Bcl-2) expression was investigated in patients (chronic nephritis, primary nephrotic syndrome or other kidney disease) that underwent renal biopsy. The study group comprised 72 patients undergoing renal biopsy. Patient profiles and renal function were collected. Concentrations of renalase and Bcl-2 were measured by immunohistochemistry. Tubular injury was detected by periodic acid Schiff staining (PAS) and renal tubular epithelial cell apoptosis was assessed by TUNEL assay. The expression of renalase was significantly lower in renal biopsy specimens than in normal kidney tissues. There was a positive linear relationship between renalase and some serum and cardiac indices; a negative correlation was found between age, eGFR, Ccr and 24-h urinary protein. Renal tubule injury index and tubular epithelial cell apoptosis index showed a negative linear correlation with renalase. The results showed that renalase probably increased the expression of Bcl-2. By two independent samples t-test, renalase levels were significantly increased in the non-hypertension group than in the hypertension group. One-way ANOVA showed that renalase expression was higher in samples with Lee’s grade III than in those with Lee’s grade V. The expression of renalase was significantly decreased in patients who underwent renal biopsy, and was also associated with blood and renal function. The research proved that renalase may reduce renal tubular injury and apoptosis of renal tubular epithelial cells through the mitochondrial apoptosis pathway, finally achieving the purpose of delaying the progress of renal failure.

Keywords

renalase / kidney disease / flavoprotein / renal function / renal puncture biopsy

References

[1] GoAS, ChertowGM, FanD, et al.. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004, 351(13): 1296-1305

[2] AnavekarNS, McMurrayJJ, VelazquezEJ, et al.. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med, 2004, 351(13): 1285-1295

[3] GoAS, MozaffarianD, RogerVL, et al.. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation, 2014, 129(3): e28-e292

[4] SchaubS, MayrM, HongerG, et al.. Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology. Transplantation, 2007, 84(1): 104-112

[5] MalyszkoJ, Bachorzewska-GajewskaH, PoniatowskiB, et al.. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail, 2009, 31(10): 910-919

[6] Haase-FielitzA, BellomoR, DevarajanP, et al.. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery—a prospective cohort study. Crit Care Med, 2009, 37(2): 553-560

[7] XuJ, LiG, WangP, et al.. Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest, 2005, 115(5): 1275-1280

[8] ZhouM, LiangT, WangY, et al.. Expression and tissue localization of renalase, a novel soluble FADdependent protein, in reproductive/steroidogenic systems. Mol Biol Rep, 2013, 40(6): 3987-3994

[9] BoomsmaF, TiptonKF. Renalase, a catecholaminemetabolising enzyme. J Neural Transm, 2007, 114(6): 775-776

[10] DesirGV. Renalase deficiency in chronic kidney disease, and its contribution to hypertension and cardiovascular disease. Curr Opin Nephrol Hypertens, 2008, 17(2): 181-185

[11] LiG, XuJ, WangP, et al.. Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation, 2008, 117(10): 1277-1282

[12] GhoshSS, KriegRJ, SicaDA, et al.. Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system. Pediatr Nephrol, 2009, 24(2): 367-377

[13] DesirGV, TangL, WangP, et al.. Renalase lowers ambulatory blood pressure by metabolizing circulating adrenaline. J Am Heart Assoc, 2012, 1(4): e002634

[14] LeeHT, KimJY, KimM, et al.. Renalase protects against ischemic AKI. J Am Soc Nephrol, 2013, 24(3): 445-455

[15] LeveyAS, BergRL, GassmanJJ, et al.. Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int, 1989, 27: S73-80

[16] LeveyAS, StevensLA, SchmidCH, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med, 2009, 150(9): 604-612

[17] EgiA, FukudaH, KawamotoM, et al.. Preoperative prediction of creatinine clearance by using serum creatinine. Masui, 2004, 53(11): 1306-1310

[18] XuJ, DesirGV. Renalase, a new renal hormone: its role in health and disease. Curr Opin Nephrol Hypertens, 2007, 16(4): 373-378

[19] Gluba-BrzozkaA, Michalska-KasiczakM, Franczyk-SkoraB, et al.. Markers of increased cardiovascular risk in patients with chronic kidney disease. Lipids Health Dis, 2014, 13: 135

[20] MatoszkaN, WisniewskaM, DolegowskaB. The mysterious properties of renalase. Postepy Biochem, 2014, 60(1): 90-93

[21] DesirGV. Regulation of blood pressure and cardiovascular function by renalase. Kidney Int, 2009, 76(4): 366-370

[22] HeB, HaoJ, ShengW, et al.. Correlation between plasma renalase level and coronary artery disease. Pak J Med Sci, 2014, 30(5): 863-967

[23] ZhouM, MaC, LiuW, et al.. Valsartan Promoting atherosclerotic plaque stabilization by upregulating renalase: a Potential-related gene of atherosclerosis. J Cardiovasc Pharmacol Ther, 2015, 20(5): 509-519

[24] WybraniecMT, Bozentowicz-WikarekM, ChudekJ, et al.. Urinary renalase concentration in patients with preserved kidney function undergoing coronary angiography. Nephrology, 2018, 23(2): 133-138

[25] LiH, GuoJ, LiuH, et al.. Renalase as a Novel Biomarker for Evaluating the Severity of Hepatic Ischemia-Reperfusion Injury. Oxid Med Cell Longev, 2016, 2016: 3178562

[26] FatimaSS, JamilZ, AlamF, et al.. Polymorphism of the renalase gene in gestational diabetes mellitus. Endocrine, 2017, 55(1): 124-129

[27] FedchenkoV, KopylovA, KozlovaN, et al.. Renalase Secreted by Human Kidney HEK293T Cells Lacks its N-Terminal Peptide: Implications for Putative Mechanisms of Renalase Action. Kidney Blood Press Res, 2016, 41(5): 593-603

[28] DesirG. Novel insights into the physiology of renalase and its role in hypertension and heart disease. Pediatr Nephrol, 2012, 27(5): 719-725

[29] MedvedevAE, VeselovskyAV, FedchenkoVI. Renalase, a new secretory enzyme responsible for selective degradation of catecholamines: achievements and unsolved problems. Biochemistry (Mosc), 2010, 75(8): 951-958

[30] MalyszkoJ, ZbrochE, MalyszkoJS, et al.. Renalase, a novel regulator of blood pressure, is predicted by kidney function in renal transplant recipients. Transplant Proc, 2011, 43(8): 3004-3007

[31] PrzybylowskiP, MalyszkoJ, KozlowskaS, et al.. Serum renalase depends on kidney function but not on blood pressure in heart transplant recipients. Transplant Proc, 2011, 43(10): 3888-3891

[32] MalyszkoJ, Koc-ZorawskaE, MalyszkoJS, et al.. Renalase, stroke, and hypertension in hemodialyzed patients. Ren Fail, 2012, 34(6): 727-731

[33] ZbrochE, MalyszkoJ, MalyszkoJ, et al.. Renalase, kidney function, and markers of endothelial dysfunction in renal transplant recipients. Pol Arch Med Wewn, 2012, 122(1-2): 40-44

[34] OguzEG, AkogluH, OkyayGU, et al.. Increased serum renalase in peritoneal dialysis patients: Is it related to cardiovascular disease risk. Nefrologia, 2017, 37(2): 189-194

[35] WuY, XuJ, VelazquezH, et al.. Renalase deficiency aggravates ischemic myocardial damage. Kidney Int, 2011, 79(8): 853-860

[36] ZhaoQ, FanZ, HeJ, et al.. Renalase gene is a novel susceptibility gene for essential hypertension: a twostage association study in northern Han Chinese population. J Mol Med (Berl), 2007, 85(8): 877-885

[37] StecA, SemczukA, FurmagaJ, et al.. Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension. Nephrol Dial Transplant, 2012, 27(11): 4162-4166

[38] WangY, LvYB, ChuC, et al.. Plasma renalase is not associated with blood pressure and brachialankle pulse wave velocity in Chinese adults with normal renal function. Kidney Blood Press Res, 2016, 41(6): 837-847